InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Carl L Gordon, Director,TenPercentOwner, is a corporate insider tracked by InsiderTape across 9 companies. The public record shows 38 open-market SEC Form 4 transactions: 33 purchases worth $59.6M and 5 sales worth $15.8M, reported from Oct 12, 21 to Apr 9, 25. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 9, 25 | CMPXCompass Therapeutics, Inc. | SELL | 3.57M | $1.59 | $5.7M |
| Feb 18, 25 | MBXMBX Biosciences, Inc. | BUY | 94.1K | $10.84 | $1.0M |
| Feb 14, 25 | MBXMBX Biosciences, Inc. | BUY | 29.5K | $9.90 | $291K |
| Sep 16, 24 | MBXMBX Biosciences, Inc. | BUY | 500.0K | $16.00 | $8.0M |
| Aug 13, 24 | KROSKeros Therapeutics, Inc. | SELL | 220.6K | $44.01 | $9.7M |
| Jul 16, 24 | TERNTerns Pharmaceuticals, Inc. | SELL | 4.0K | $10.00 | $40K |
| Jul 15, 24 | TERNTerns Pharmaceuticals, Inc. | SELL | 39.4K | $10.00 | $394K |
| May 15, 24 | PHGEBiomX Inc. | SELL | 24.3K | $0.38 | $9K |
| Jan 30, 24 | AVBPArriVent Biopharma, Inc. | BUY | 222.2K | $18.00 | $4.0M |
| Jan 25, 24 | ACETAdicet Bio, Inc. | BUY | 1.84M | $2.40 | $4.4M |
| Jul 17, 23 | THRXTheseus Pharmaceuticals, Inc. | BUY | 328.5K | $3.05 | $1.0M |
| Jun 27, 23 | ACETAdicet Bio, Inc. | BUY | 442.0K | $2.09 | $924K |
| May 5, 23 | KNTEKinnate Biopharma Inc. | BUY | 490.5K | $2.82 | $1.4M |
| May 4, 23 | KNTEKinnate Biopharma Inc. | BUY | 313.0K | $2.75 | $861K |
| May 2, 23 | KNTEKinnate Biopharma Inc. | BUY | 220.6K | $2.67 | $589K |
| May 1, 23 | KNTEKinnate Biopharma Inc. | BUY | 467.1K | $2.62 | $1.2M |
| Apr 28, 23 | KNTEKinnate Biopharma Inc. | BUY | 228.8K | $2.55 | $583K |
| Dec 23, 22 | TERNTerns Pharmaceuticals, Inc. | BUY | 137.9K | $7.25 | $1.0M |
| Nov 8, 22 | CMPXCompass Therapeutics, Inc. | BUY | 402.0K | $3.21 | $1.3M |
| Nov 7, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 192.0K | $5.21 | $1.0M |
| Aug 16, 22 | TERNTerns Pharmaceuticals, Inc. | BUY | 2.47M | $2.42 | $6.0M |
| May 13, 22 | CMPXCompass Therapeutics, Inc. | BUY | 30.7K | $2.49 | $76K |
| May 12, 22 | CMPXCompass Therapeutics, Inc. | BUY | 97.1K | $2.35 | $228K |
| May 11, 22 | CMPXCompass Therapeutics, Inc. | BUY | 64.7K | $1.79 | $116K |
| May 10, 22 | CMPXCompass Therapeutics, Inc. | BUY | 24.4K | $1.60 | $39K |
| May 9, 22 | CMPXCompass Therapeutics, Inc. | BUY | 90.7K | $1.56 | $142K |
| May 6, 22 | CMPXCompass Therapeutics, Inc. | BUY | 10.2K | $1.63 | $17K |
| Feb 15, 22 | KNTEKinnate Biopharma Inc. | BUY | 9.0K | $9.96 | $90K |
| Feb 14, 22 | KNTEKinnate Biopharma Inc. | BUY | 20.7K | $9.98 | $207K |
| Feb 11, 22 | KNTEKinnate Biopharma Inc. | BUY | 156.0K | $10.22 | $1.6M |
| Jan 21, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 111.9K | $9.97 | $1.1M |
| Jan 20, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 35.0K | $9.95 | $348K |
| Jan 19, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 11.5K | $9.97 | $115K |
| Jan 13, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 17.3K | $9.43 | $163K |
| Jan 12, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 18.9K | $10.06 | $190K |
| Jan 11, 22 | THRXTheseus Pharmaceuticals, Inc. | BUY | 6.9K | $10.67 | $74K |
| Nov 4, 21 | CMPXCompass Therapeutics, Inc. | BUY | 3.57M | $3.50 | $12.5M |
| Oct 12, 21 | THRXTheseus Pharmaceuticals, Inc. | BUY | 562.5K | $16.00 | $9.0M |